Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4889 USD | +1.88% | +7.24% | -59.26% |
04-02 | Centogene Gets Nasdaq Noncompliance Notice | MT |
03-19 | Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics | MT |
Sales 2023 * | 48.62M 51.99M 4.16B | Sales 2024 * | 59.5M 63.62M 5.09B | Capitalization | 12.76M 13.64M 1.09B |
---|---|---|---|---|---|
Net income 2023 * | -48M -51.32M -4.11B | Net income 2024 * | -45M -48.11M -3.85B | EV / Sales 2023 * | 0.26 x |
Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 0.21 x |
P/E ratio 2023 * |
-0.29
x | P/E ratio 2024 * |
-0.47
x | Employees | 444 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 69.49% |
1 day | +1.88% | ||
1 week | +7.24% | ||
Current month | -31.14% | ||
1 month | -29.14% | ||
3 months | -57.11% | ||
6 months | -53.60% | ||
Current year | -59.26% |
Managers | Title | Age | Since |
---|---|---|---|
Kim Stratton
CEO | Chief Executive Officer | 62 | 19/12/21 |
Director of Finance/CFO | - | 07/02/22 | |
Chief Tech/Sci/R&D Officer | 64 | 15/08/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peer Schatz
CHM | Chairman | 57 | 15/03/20 |
Hubert Birner
BRD | Director/Board Member | 57 | 30/06/17 |
Flemming Ørnskov
BRD | Director/Board Member | 66 | 31/03/19 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.4889 | +1.88% | 6,941 |
25/04/24 | 0.4799 | +4.10% | 7,168 |
24/04/24 | 0.461 | -3.96% | 19,900 |
23/04/24 | 0.48 | +2.11% | 71,989 |
22/04/24 | 0.4701 | +3.11% | 434,353 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.26% | 13.62M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CNTG Stock